Howard Chan

1.1k total citations
30 papers, 742 citations indexed

About

Howard Chan is a scholar working on Finance, Accounting and Molecular Biology. According to data from OpenAlex, Howard Chan has authored 30 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Finance, 16 papers in Accounting and 7 papers in Molecular Biology. Recurrent topics in Howard Chan's work include Financial Markets and Investment Strategies (16 papers), Corporate Finance and Governance (11 papers) and Financial Reporting and Valuation Research (6 papers). Howard Chan is often cited by papers focused on Financial Markets and Investment Strategies (16 papers), Corporate Finance and Governance (11 papers) and Financial Reporting and Valuation Research (6 papers). Howard Chan collaborates with scholars based in Australia, United States and Singapore. Howard Chan's co-authors include Robert W. Faff, Philip Gharghori, Roger J. Daly, Paul Docherty, Elizabeth V. Nguyen, Xiuquan Ma, Rachel S. Lee, Luxi Zhang, George Wong and Kaylene J. Simpson and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Cancer Research.

In The Last Decade

Howard Chan

30 papers receiving 710 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Howard Chan Australia 16 309 254 201 192 97 30 742
Lewis D. Johnson Canada 12 143 0.5× 116 0.5× 160 0.8× 120 0.6× 50 0.5× 39 602
Joshua Madsen United States 13 254 0.8× 296 1.2× 210 1.0× 280 1.5× 39 0.4× 26 863
Ricardo Correa United States 22 1.1k 3.5× 589 2.3× 480 2.4× 198 1.0× 117 1.2× 97 2.0k
Jishuang Yu China 10 85 0.3× 68 0.3× 270 1.3× 149 0.8× 53 0.5× 15 644
Dylan C. Thomas United Kingdom 17 455 1.5× 538 2.1× 335 1.7× 378 2.0× 73 0.8× 44 1.7k
Zhiwei Xu China 15 246 0.8× 102 0.4× 485 2.4× 166 0.9× 100 1.0× 81 981
Masako Ueda United States 16 79 0.3× 474 1.9× 325 1.6× 83 0.4× 19 0.2× 52 1.1k
Hsiao‐Hui Lee Taiwan 17 70 0.2× 150 0.6× 211 1.0× 259 1.3× 59 0.6× 53 902
Valentina Flamini United States 12 378 1.2× 421 1.7× 274 1.4× 157 0.8× 36 0.4× 24 795
Qiping Xu United States 15 169 0.5× 193 0.8× 274 1.4× 126 0.7× 25 0.3× 31 752

Countries citing papers authored by Howard Chan

Since Specialization
Citations

This map shows the geographic impact of Howard Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard Chan more than expected).

Fields of papers citing papers by Howard Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard Chan. The network helps show where Howard Chan may publish in the future.

Co-authorship network of co-authors of Howard Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Howard Chan. A scholar is included among the top collaborators of Howard Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Howard Chan. Howard Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nguyen, Elizabeth V., Shih‐Ping Su, Karel Novy, et al.. (2020). FGFR3 signaling and function in triple negative breast cancer. Cell Communication and Signaling. 18(1). 13–13. 55 indexed citations
2.
Ma, Xiuquan, Luxi Zhang, Jiangning Song, et al.. (2019). Characterization of the Src-regulated kinome identifies SGK1 as a key mediator of Src-induced transformation. Nature Communications. 10(1). 296–296. 27 indexed citations
3.
Nguyen, Elizabeth V., Brooke Pereira, Mitchell G. Lawrence, et al.. (2019). Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor Microenvironment. Molecular & Cellular Proteomics. 18(7). 1410–1427. 77 indexed citations
4.
Nguyen, Elizabeth V., Margaret M. Centenera, Max Moldovan, et al.. (2018). Identification of Novel Response and Predictive Biomarkers to Hsp90 Inhibitors Through Proteomic Profiling of Patient-derived Prostate Tumor Explants. Molecular & Cellular Proteomics. 17(8). 1470–1486. 26 indexed citations
5.
Chan, Howard, et al.. (2018). Explanations of cycles in seasoned equity offerings: An examination of the choice between rights issues and private placements. Pacific-Basin Finance Journal. 50. 16–25. 6 indexed citations
6.
Patel, Onisha, Michael D. W. Griffin, Santosh Panjikar, et al.. (2017). Structure of SgK223 pseudokinase reveals novel mechanisms of homotypic and heterotypic association. Nature Communications. 8(1). 1157–1157. 33 indexed citations
7.
Liu, Ling, Rachel S. Lee, Xiuquan Ma, et al.. (2016). Homo- and Heterotypic Association Regulates Signaling by the SgK269/PEAK1 and SgK223 Pseudokinases. Journal of Biological Chemistry. 291(41). 21571–21583. 25 indexed citations
8.
Croucher, David R., Falko Hochgräfe, Luxi Zhang, et al.. (2013). Involvement of Lyn and the Atypical Kinase SgK269/PEAK1 in a Basal Breast Cancer Signaling Pathway. Cancer Research. 73(6). 1969–1980. 67 indexed citations
9.
Docherty, Paul, et al.. (2012). Can we treat empirical regularities as state variables in the ICAPM? Evidence from Australia. Pacific-Basin Finance Journal. 22. 107–124. 4 indexed citations
10.
Docherty, Paul, et al.. (2011). Asset tangibility, industry representation and the cross section of equity returns. Australian Journal of Management. 36(1). 75–87. 13 indexed citations
11.
Chan, Howard, Robert W. Faff, & Paul Kofman. (2011). Is default risk priced in Australian equity? Exploring the role of the business cycle. Australian Journal of Management. 36(2). 217–246. 13 indexed citations
12.
Docherty, Paul, et al.. (2011). Australian evidence on the implementation of the size and value premia. Accounting and Finance. 53(2). 367–391. 9 indexed citations
13.
Chan, Howard, Xin Chang, Robert W. Faff, & George Wong. (2010). Financial constraints and stock returns — Evidence from Australia. Pacific-Basin Finance Journal. 18(3). 306–318. 26 indexed citations
14.
Docherty, Paul, et al.. (2010). Tangibility and investment irreversibility in asset pricing. Accounting and Finance. 50(4). 809–827. 12 indexed citations
15.
Chan, Howard, Robert W. Faff, Yoon Khei Ho, & Alan Ramsay. (2009). The effects of forecast specificity on the asymmetric short‐window share market response to management earnings forecasts. Accounting Research Journal. 22(3). 237–261. 1 indexed citations
16.
Chan, Howard, et al.. (2009). Trading volume and information asymmetry: routine versus nonroutine earnings announcements in Australia. Applied Financial Economics. 19(21). 1737–1752. 3 indexed citations
17.
Gharghori, Philip, Howard Chan, & Robert W. Faff. (2007). Are the Fama-French Factors Proxying Default Risk?. Australian Journal of Management. 32(2). 223–249. 68 indexed citations
18.
Chan, Howard, et al.. (2004). What’s in a Name? Evidence on Corporate Name Changes from the Australian Capital Market. Pacific Accounting Review. 16(1). 57–76. 26 indexed citations
19.
Faff, Robert W. & Howard Chan. (1998). A test of the intertemporal CAPM in the Australian equity market. Journal of International Financial Markets Institutions and Money. 8(2). 175–188. 7 indexed citations
20.
Faff, Robert W. & Howard Chan. (1998). A multifactor model of gold industry stock returns: evidence from the Australian equity market. Applied Financial Economics. 8(1). 21–28. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lewis D. Johnson Breakdown of academic impact, for papers by Joshua Madsen Breakdown of academic impact, for papers by Ricardo Correa Breakdown of academic impact, for papers by Jishuang Yu Breakdown of academic impact, for papers by Dylan C. Thomas Breakdown of academic impact, for papers by Zhiwei Xu Breakdown of academic impact, for papers by Masako Ueda Breakdown of academic impact, for papers by Hsiao‐Hui Lee Breakdown of academic impact, for papers by Valentina Flamini Breakdown of academic impact, for papers by Qiping Xu
Rankless by CCL
2026